Liabilities, Current of U S PHYSICAL THERAPY INC /NV from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
U S PHYSICAL THERAPY INC /NV quarterly Liabilities, Current in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • U S PHYSICAL THERAPY INC /NV Liabilities, Current for the quarter ending 30 Sep 2025 was $115,080,000, a 0.19% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)

U S PHYSICAL THERAPY INC /NV Quarterly Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $115,080,000 -$220,000 -0.19% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $118,842,000 +$11,743,000 +11% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $123,795,000 +$21,259,000 +21% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $116,283,000 +$14,098,000 +14% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 $115,300,000 +$32,944,000 +40% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $107,099,000 +$21,283,000 +25% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $102,536,000 +$11,703,000 +13% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $102,185,000 +$16,696,000 +20% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $82,356,000 +$868,000 +1.1% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $85,816,000 +$711,000 +0.84% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $90,833,000 +$1,813,000 +2% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $85,489,000 +$2,008,000 +2.4% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $81,488,000 -$180,000 -0.22% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $85,105,000 +$9,726,000 +13% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $89,020,000 -$1,805,000 -2% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $83,481,000 -$10,011,000 -11% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $81,668,000 -$11,532,000 -12% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $75,379,000 -$11,974,000 -14% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $90,825,000 +$19,676,000 +28% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $93,492,000 +$32,929,000 +54% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $93,200,000 +$30,402,000 +48% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $87,353,000 +$30,333,000 +53% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $71,149,000 +$2,219,000 +3.2% 31 Mar 2020 10-Q 21 May 2020 2020 Q1
Q4 2019 $60,563,000 +$18,617,000 +44% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $62,798,000 +$15,834,000 +34% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $57,020,000 +$15,131,000 +36% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $68,930,000 +$23,549,000 +52% 31 Mar 2019 10-Q 06 May 2019 2019 Q1
Q4 2018 $41,946,000 +$2,395,000 +6.1% 31 Dec 2018 10-K 28 Feb 2020 2019 FY
Q3 2018 $46,964,000 +$10,973,000 +30% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 $41,889,000 +$6,696,000 +19% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 $45,381,000 +$11,346,000 +33% 31 Mar 2018 10-Q 07 May 2018 2018 Q1
Q4 2017 $39,551,000 +$14,934,000 +61% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q3 2017 $35,991,000 +$9,608,000 +36% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 $35,193,000 +$6,208,000 +21% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 $34,035,000 +$9,854,000 +41% 31 Mar 2017 10-Q 29 Jun 2017 2017 Q1
Q4 2016 $24,617,000 +$5,610,000 +30% 31 Dec 2016 10-K 14 Mar 2018 2017 FY
Q3 2016 $26,383,000 +$5,022,000 +24% 30 Sep 2016 10-K 07 Jun 2017 2016 FY
Q2 2016 $28,985,000 +$7,288,000 +34% 30 Jun 2016 10-K 07 Jun 2017 2016 FY
Q1 2016 $24,181,000 +$2,779,000 +13% 31 Mar 2016 10-K 07 Jun 2017 2016 FY
Q4 2015 $19,007,000 -$6,497,000 -25% 31 Dec 2015 10-K 07 Jun 2017 2016 FY
Q3 2015 $21,361,000 -$471,000 -2.2% 30 Sep 2015 10-K 07 Jun 2017 2016 FY
Q2 2015 $21,697,000 -$1,100,000 -4.8% 30 Jun 2015 10-K 07 Jun 2017 2016 FY
Q1 2015 $21,402,000 +$2,057,000 +11% 31 Mar 2015 10-K 07 Jun 2017 2016 FY
Q4 2014 $25,504,000 +$2,332,000 +10% 31 Dec 2014 10-K 04 Mar 2016 2015 FY
Q3 2014 $21,832,000 +$5,177,000 +31% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 $22,797,000 +$5,424,000 +31% 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 $19,345,000 +$5,440,000 +39% 31 Mar 2014 10-Q 09 May 2014 2014 Q1
Q4 2013 $23,172,000 +$6,865,000 +42% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q3 2013 $16,655,000 +$1,709,000 +11% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 $17,373,000 +$1,165,000 +7.2% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 $13,905,000 +$1,389,000 +11% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 $16,307,000 -$17,000 -0.1% 31 Dec 2012 10-K 11 Mar 2014 2013 FY
Q3 2012 $14,946,000 +$1,254,000 +9.2% 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 $16,208,000 +$1,523,000 +10% 30 Jun 2012 10-Q/A 06 Sep 2012 2012 Q2
Q1 2012 $12,516,000 31 Mar 2012 10-Q 04 May 2012 2012 Q1
Q4 2011 $16,324,000 +$2,093,000 +15% 31 Dec 2011 10-K 12 Mar 2013 2012 FY
Q3 2011 $13,692,000 30 Sep 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 $14,685,000 30 Jun 2011 10-Q 04 Aug 2011 2011 Q2
Q4 2010 $14,231,000 31 Dec 2010 10-K 09 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.